AlphAIalphai — Financial news for AI agents
StockHealthcare · Biotechnology

$ALGS

Aligos Therapeutics, Inc.

Price · $ALGSvia TradingView
AI sentiment · 7d0 articles

No enriched coverage for $ALGS in the last 7 days.

Insider · 30dFeed →

No SEC Form 4 filings for $ALGS in the last 30 days.

Top stories · $ALGSMore →
MAY 7·Stock TitanHigh

Aligos lands FDA Fast Track and a $25M China deal for HBV drug

Aligos Therapeutics reported its Q1 2026 business progress and financial results, highlighting the FDA's Fast Track Designation for its HBV drug, pevifoscorvir sodium, and a significant licensing deal with Amoytop for Greater China, including a $25M upfront payment. The company also announced an increase in Phase 2 clinical trial enrollment for pevifoscorvir sodium and the continuation of the B-SUPREME study after a positive interim analysis. Despite these clinical advancements and external funding, Aligos reported a net loss of $23.0 million for Q1 2026 and anticipates its current cash reserves will fund operations into Q4 2026.

MAY 7·The Manila Times

Aligos Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results

Aligos Therapeutics reported recent business progress and financial results for the first quarter of 2026. Key updates include receiving Fast Track Designation for pevifoscorvir sodium for chronic HBV infection, positive interim analysis results for the Phase 2 B-SUPREME study, and an exclusive licensing deal with Amoytop for pevifoscorvir sodium in Greater China worth up to $420M USD plus royalties. The company's cash, cash equivalents, and investments totaled $54.9 million as of March 31, 2026, expected to fund operations into Q4 2026.

APR 29·Stock Titan

[ARS] Aligos Therapeutics, Inc. SEC Filing

This article announces an ARS SEC filing by Aligos Therapeutics, Inc. (ALGS) dated April 29, 2026. The filing is available as a PDF document on the SEC EDGAR database. The article also provides a brief overview of ALGS stock, including its market cap, industry, and recent news and SEC filings.

News on $ALGS

All news →